Skip to content

Julia Bornemann

5 papers in the library · 90 citations · publishing 2021-2025

Papers

Sort Most recent Most cited

Defining ‘psychedelic’

December 4, 2025 Avery Ostrand, Matthew M. Nour, Christopher Timmermann et al. 2 citations preprint

Humphry Osmond coined the term ‘psychedelic’ in 1956, conjoining ‘psyche’ for ‘soul’ and ‘delic’ from ‘dêlos’ for ‘to manifest’ or ‘illuminate.’ Soul-illumination is an adjective that describes a psychological state or process. However, Osmond’s intention was to use the adjective to name— not just a state— but a category of drug that can induce the subjective effect as its principal action;...

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”

Frontiers in Psychiatry June 4, 2024 Julia Bornemann, James B. Close, Kirran Ahmad et al. 11 citations

Background Chronic pain is a leading cause of disability worldwide. Fibromyalgia is a particularly debilitating form of widespread chronic pain. Fibromyalgia remains poorly understood, and treatment options are limited or moderately effective at best. Here, we present a protocol for a mechanistic study investigating the effects of psychedelic-assisted-therapy in a fibromyalgia population. The...

ARC: a framework for access, reciprocity and conduct in psychedelic therapies

Frontiers in Psychology May 11, 2023 Hannah Thurgur, Meg J. Spriggs, Ashleigh Murphy-Beiner et al. 13 citations

The field of psychedelic assisted therapy (PAT) is growing at an unprecedented pace. The immense pressures this places on those working in this burgeoning field have already begun to raise important questions about risk and responsibility. It is imperative that the development of an ethical and equitable infrastructure for psychedelic care is prioritized to support this rapid expansion of PAT...

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

Frontiers in Psychiatry November 12, 2021 Julia Bornemann, James B. Close, Meg J. Spriggs et al. 43 citations

Background: Chronic Pain is among the leading causes of disability worldwide with up to 60% of patients suffering from comorbid depression. Psychedelic-assisted therapy has recently been found effective in treating a host of mental health issues including depression and has historically been found to be useful in treating pain. Reports of self-medication for chronic pain using psychedelic drugs...

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research

Frontiers in Psychiatry September 30, 2021 James B. Close, Julia Bornemann, Maria Piggin et al. 21 citations

Within the context of scientific research, patient and public involvement (PPI) is defined as research performed “with” or “by” patients and members of the public, rather than “to,” “about”, or “for” them. When carried out systematically and thoughtfully, PPI has the potential to strengthen the quality and impact of research by fostering accountability, transparency, and relevance. There exist...